SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000891293-18-000078
Filing Date
2018-08-03
Accepted
2018-08-02 17:40:51
Documents
45
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cti10q06302018.htm 10-Q 904056
2 EXHIBIT 3.1 ex31-certificateofamendment.htm EX-3.1 9743
3 EXHIBIT 10.3 ex103-firstamendmenttoloan.htm EX-10.3 44043
4 EXHIBIT 31.1 ex311-ceo302.htm EX-31.1 10997
5 EXHIBIT 31.2 ex312-cfo302.htm EX-31.2 12122
6 EXHIBIT 32 ex32-ceocfo906.htm EX-32 11886
  Complete submission text file 0000891293-18-000078.txt   3695077

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ctic-20180630.xml EX-101.INS 546192
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ctic-20180630.xsd EX-101.SCH 23241
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ctic-20180630_cal.xml EX-101.CAL 71631
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ctic-20180630_def.xml EX-101.DEF 142861
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ctic-20180630_lab.xml EX-101.LAB 406664
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ctic-20180630_pre.xml EX-101.PRE 223989
Mailing Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-28386 | Film No.: 18989730
SIC: 2834 Pharmaceutical Preparations